"Baby Bios" Get a Good Start in the UK
This article was originally published in Start Up
Executive Summary
UK biotech incubator Medical Marketing International Group PLC enjoyed a taste of success earlier this month when Cambridge-based CellFactors PLC, the most advanced of MMI's current wave of investments, was granted a US patent for its method of producing stem cells and preventing them from proliferating once they are transplanted into humans.
You may also be interested in...
Radiopharmaceuticals: A New Frontier In Precision Cancer Therapy
Growing interest in radioligand-based cancer therapies reflects the class’s unique advantages – including the ability to “see what you treat.”
The New Antibodies Revolutionizing Medicine
Nucleic acid-based therapies are poised to revolutionize medicine – just as antibodies did thirty years ago.
What Next In Oncology?
Oncology dominates pharma sales and pipeline league tables. But where is the next Keytruda?